Enhanced in-Vitro and in-Vivo Targeting of Rituximab Sensitive and Resistant Burkitt Lymphoma (BL) By Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer Cells in Combination with a Histone Deacetylase Inhibitor, Romidepsin

Saved in:
Bibliographic Details
Published in:Biology of blood and marrow transplantation 2016-03, Vol.22 (3), p.S392-S392
Main Authors: Chu, Yaya, PhD, Yahr, Ashlin, BA, Cheng, Bokun, MS, Hang, Brian, Ayello, Janet, MS, MT(ASCP), Barth, Matthew, MD, Cairo, Mitchell S., MD
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1083-8791
1523-6536
DOI:10.1016/j.bbmt.2015.11.915